113 related articles for article (PubMed ID: 10757045)
1. Inhibitory action of roxithromycin on tumour necrosis factor-alpha production from mast cells in vitro.
Shimane T; Asano K; Mizutani T; Suzaki H
In Vivo; 1999; 13(6):503-6. PubMed ID: 10757045
[TBL] [Abstract][Full Text] [Related]
2. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro.
Shimane T; Asano K; Suzuki M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2001 Dec; 10(6):323-32. PubMed ID: 11817673
[TBL] [Abstract][Full Text] [Related]
3. Suppressive activity of a macrolide antibiotic, roxithromycin, on pro-inflammatory cytokine production in vitro and in vivo.
Suzaki H; Asano K; Ohki S; Kanai K; Mizutani T; Hisamitsu T
Mediators Inflamm; 1999; 8(4-5):199-204. PubMed ID: 10704073
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory action of a macrolide antibiotic, roxithromycin, on co-stimulatory molecule expressions in vitro and in vivo.
Suzuki M; Asano K; Yu M; Hisamitsu T; Suzaki H
Mediators Inflamm; 2002 Aug; 11(4):235-44. PubMed ID: 12396475
[TBL] [Abstract][Full Text] [Related]
5. Roxithromycin specifically inhibits development of collagen induced arthritis and production of proinflammatory cytokines by human T cells and macrophages.
Urasaki Y; Nori M; Iwata S; Sasaki T; Hosono O; Kawasaki H; Tanaka H; Dang NH; Ikeda E; Morimoto C
J Rheumatol; 2005 Sep; 32(9):1765-74. PubMed ID: 16142877
[TBL] [Abstract][Full Text] [Related]
6. Suppression of matrix metalloproteinase-9 production from neutrophils by a macrolide antibiotic, roxithromycin, in vitro.
Kanai K; Asano K; Hisamitsu T; Suzaki H
Mediators Inflamm; 2004 Dec; 13(5-6):313-9. PubMed ID: 15770046
[TBL] [Abstract][Full Text] [Related]
7. Effects of roxithromycin on tumor necrosis factor-alpha-induced vascular endothelial growth factor expression in human periodontal ligament cells in culture.
Oyama T; Sakuta T; Matsushita K; Maruyama I; Nagaoka S; Torii M
J Periodontol; 2000 Oct; 71(10):1546-53. PubMed ID: 11063386
[TBL] [Abstract][Full Text] [Related]
8. Influence of the anti-allergic agent, azelastine, on tumor necrosis factor-alpha (TNF-alpha) secretion from cultured mouse mast cells.
Matsuo S; Takayama S
In Vivo; 1998; 12(5):481-4. PubMed ID: 9827354
[TBL] [Abstract][Full Text] [Related]
9. Roxithromycin inhibits tumor necrosis factor-alpha-induced matrix metalloproteinase-1 expression through regulating mitogen-activated protein kinase phosphorylation and Ets-1 expression.
Oyama T; Matsushita K; Sakuta T; Tokuda M; Tatsuyama S; Nagaoka S; Torii M
J Periodontal Res; 2007 Feb; 42(1):53-61. PubMed ID: 17214640
[TBL] [Abstract][Full Text] [Related]
10. Runt-related gene 2 is involved in the inhibition of matrix metalloproteinase-13 expression by roxithromycin in human gingival epithelial cell cultures.
Tabuchi S; Sakuta T; Oyama T; Tokuda M; Tatsuyama S; Kajihara T; Nagaoka S; Beppu M; Sugihara K; Ikebe T; Shirasuna K; Torii M
J Periodontal Res; 2009 Jun; 44(3):283-8. PubMed ID: 19453496
[TBL] [Abstract][Full Text] [Related]
11. Induction of HSP70 is dispensable for anti-inflammatory action of heat shock or NSAIDs in mast cells.
Mortaz E; Redegeld FA; Bloksma N; Dunsmore K; Denenberg A; Wong HR; Nijkamp FP; Engels F
Exp Hematol; 2006 Apr; 34(4):414-23. PubMed ID: 16569588
[TBL] [Abstract][Full Text] [Related]
12. Suppressive activity of a macrolide antibiotic, roxithromycin on co-stimulatory molecule expression on mouse splenocytes in vivo.
Kawazu K; Kurokawa M; Asano K; Mita A; Adachi M
Mediators Inflamm; 2000; 9(1):39-43. PubMed ID: 10877454
[TBL] [Abstract][Full Text] [Related]
13. Authentic 17 kDa tumour necrosis factor alpha is synthesized and released by canine mast cells and up-regulated by stem cell factor.
Thomas PS; Pennington DW; Schreck RE; Levine TM; Lazarus SC
Clin Exp Allergy; 1996 Jun; 26(6):710-8. PubMed ID: 8809429
[TBL] [Abstract][Full Text] [Related]
14. Inhibitory action of roxithromycin on histamine release and prostaglandin D2 production from beta-defensin 2-stimulated mast cells.
Kase K; Hua J; Yokoi H; Ikeda K; Nagaoka I
Int J Mol Med; 2009 Mar; 23(3):337-40. PubMed ID: 19212651
[TBL] [Abstract][Full Text] [Related]
15. HMG-CoA reductase inhibitor simvastatin inhibits proinflammatory cytokine production from murine mast cells.
Kagami S; Kanari H; Suto A; Fujiwara M; Ikeda K; Hirose K; Watanabe N; Iwamoto I; Nakajima H
Int Arch Allergy Immunol; 2008; 146 Suppl 1():61-6. PubMed ID: 18504409
[TBL] [Abstract][Full Text] [Related]
16. Effects of roxithromycin on proliferation of peripheral blood mononuclear cells and production of lipopolysaccharide-induced cytokines.
Yoshimura T; Kurita C; Yamazaki F; Shindo J; Morishima I; Machida K; Sumita T; Horiba M; Nagai H
Biol Pharm Bull; 1995 Jun; 18(6):876-81. PubMed ID: 7550124
[TBL] [Abstract][Full Text] [Related]
17. Fatty acid-binding protein regulates LPS-induced TNF-alpha production in mast cells.
Yamamoto N; Kaneko I; Motohashi K; Sakagami H; Adachi Y; Tokuda N; Sawada T; Furukawa H; Ueyama Y; Fukunaga K; Ono M; Kondo H; Owada Y
Prostaglandins Leukot Essent Fatty Acids; 2008; 79(1-2):21-6. PubMed ID: 18678477
[TBL] [Abstract][Full Text] [Related]
18. Treatment with Y-40138, a multiple cytokine production modulator, inhibits lipopolysaccharide- or tumour necrosis factor-alpha-induced production of pro-inflammatory cytokines and augments interleukin-10.
Fukuda T; Hisadome M; Komatsu H
J Pharm Pharmacol; 2005 Nov; 57(11):1461-6. PubMed ID: 16259779
[TBL] [Abstract][Full Text] [Related]
19. Suppression of co-stimulatory molecule expressions on splenic B lymphocytes by a macrolide antibiotic, roxithromycin in vitro.
Asano K; Suzuki M; Shimane T; Suzaki H
Int Immunopharmacol; 2001 Jul; 1(7):1385-92. PubMed ID: 11460318
[TBL] [Abstract][Full Text] [Related]
20. Ceramide inhibits LPS-induced production of IL-5, IL-10, and IL-13 from mast cells.
Chiba N; Masuda A; Yoshikai Y; Matsuguchi T
J Cell Physiol; 2007 Oct; 213(1):126-36. PubMed ID: 17458900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
